APA (7th ed.) Citation

Nappi, R. E., Cagnacci, A., Di Carlo, C., Genazzani, A. D., Villa, P., & Simoncini, T. (2025). Targeting vasomotor symptoms with the new drug fezolinetant – an expert overview. Gynecological Endocrinology, 41(1), 1. https://doi.org/10.1080/09513590.2025.2526560

Chicago Style (17th ed.) Citation

Nappi, Rossella E., Angelo Cagnacci, Costantino Di Carlo, Alessandro D. Genazzani, Paola Villa, and Tommaso Simoncini. "Targeting Vasomotor Symptoms with the New Drug Fezolinetant – an Expert Overview." Gynecological Endocrinology 41, no. 1 (2025): 1. https://doi.org/10.1080/09513590.2025.2526560.

MLA (9th ed.) Citation

Nappi, Rossella E., et al. "Targeting Vasomotor Symptoms with the New Drug Fezolinetant – an Expert Overview." Gynecological Endocrinology, vol. 41, no. 1, 2025, p. 1, https://doi.org/10.1080/09513590.2025.2526560.